ABAXIS Inc. (ABAX)
Symbol Info
Listed Symbol ABAX
Name ABAXIS Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $0.60
Latest Fiscal Date 2018-03-31
Latest Fiscal Revenue $244,700,000
Latest Fiscal EPS $1.17
Price Info
21 Day Moving Average $83.1933
21 Day EMA $83.064120
50 Day Moving Average $83.0899
50 Day EMA $81.425180
200 Day EMA $69.691720
200 Day Moving Average 66.338260
52 Week High $83.98
52 Week Low $43.66
52 Week Change $78.489700
Alpha 0.003428
Beta 1.4398
Standard Deviation 0.096504
R2 0.174023
Periods 60
Share Information
10 Day Average Volume 154,925
20 Day Average Volume 174,125
30 Day Average Volume 206,639
50 Day Average Volume 258,341
Outstanding Shares 22,870,967
Float Shares 21,299,733
Percent Float 93.13%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 219
Institute Holdings Date 2018-06-30
Institute Bought Previous 3 Months 860,550
Institute Holdings Percent 91.700000
Institute Sold Previous 3 Months 2,174,394
Insider Holdings Date 2018-07-31
Insider Bought Previous 3 Months 120,700
Insider Holdings Percent 6.90%
Insider Sold Previous 3 Months 1,148,891
Insiders Shares Owned 1,571,234
Price Change
7 Day Price Change $-0.0999985
7 Day Percent Change -0.12%
21 Day Price Change $-0.25
21 Day Percent Change -0.30%
30 Day Price Change $-0.0100021
30 Day Percent Change -0.01%
Month To Date Price Change $-0.01
Month To Date Percent -0.01%
90 Day Price Change $16.573662
90 Day Percent Change 24.95%
Quarter To Date $-0.010002
Quarter To Date Percent -0.01%
180 Day Price Change $11.671921
180 Day Percent Change 16.36%
200 Day Price Change $20.840542
200 Day Percent Change 33.53%
Year To Date $33.702490
Year To Date Percent 68.37%
Profile
Description Abaxis Inc is a worldwide developer, manufacturer, and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. The company's primary products are point of care diagnostic instruments and consumables used in the medical market, and point of care diagnostic instruments and consumables used in the veterinary market. It generates a majority of its revenue from the Veterinary Market.
Details
Issue Type CS
Market Cap $1,898,290,261
Sec Type EQS
Auditor Burr Pilger Mayer, Inc.
Total Shares Outstanding -
CEO Clinton H. Severson
Employees 656
Last Audit UQ
Classification
CIK 0000881890
Industry Medical Diagnostics & Research
Sector Healthcare
NAICS In-Vitro Diagnostic Substance Manufacturing(325413)
Info
Address 3240 Whipple Road
Union City, CA 94587
Website http://www.abaxis.com
Facisimile +1 510 441-6150
Telephone +1 510 675-6500
Email investors@abaxis.com
Key Ratios
Profitability
EBIT Margin 15.80
EBITDA Margin 19.1
Pre-Tax Profit Margin 18.7
Profit Margin Cont 11.18
Gross Margin 54.60
Profit Margin TOT 11.18
Income Statements
Revenue $186,442,000
Revenue Per Share $8.1519
Revenue 3 Years $3.84
Revenue 5 Years $6.50
Valuation Measures
PE Ratio 70.90
Enterprise Value $1,731,684,261
Price To Sales 10.181666
Price To Free Cash 109.600000
PE High Last 5 Years 106.2
Price To Book 6.5
Price To Cash Flow 44.1
PE Low Last 5 Years 26.1
Price To Tangible Book 6.6
Financial Strength
Total Debt To Equity -
Int Coverage -
Current Ratio 6.0
Leverage Ratio 1.2
Quick Ratio 4.9
Long Term Debt To Capital -
Assets
Receivables Turnover 1.8
Invoice Turnover 2.60
Assets Turnover 0.20
Management Effectiveness
Return Assets 8.40
Return On Equity 9.76
Return On Capital 7.42
Dividends
Dividend 3 Years $14.84
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type Cash


Your Recent History
NASDAQ
ABAX
Abaxis, In..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.